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1. Abstract 
 
Background: Postoperative Delirium (POD) is a well-known complication, occurring mainly in 
elderly patients. The increase in surgical interventions in the elderly population is a challenge for 
postoperative care units to recognize, treat and prevent this condition. Despite the frequency of 
this event, there is still space for improvement of management, prophylaxis and treatment. There 
are a variety of perioperative measures that are currently investigated to possibly reduce the POD 
incidence and / or to improve its diagnosis and management. To summarize and analyze recent 
clinical studies in the non-cardiac population, we performed a systematic review. 
Objective and Methods: To examine whether there is potential for optimization in modern 
POD prevention guidelines we reviewed the current literature including prospective clinical trials 
that assessed perioperative interventions and its effect on the POD incidence.  
Results: We found 23 prospective studies including a total of 4’525 patients. The described in-
terventions ranged from simple use of pharmaceutical agents to complex treatment protocols. 
Conclusion and Implications: According to the current literature, there is no strong evidence 
that a specific perioperative measure reduces the POD incidence. However, there are single studies 
showing a positive effect on the POD incidence with simple measures like geriatric consultation 
or haloperidol prophylaxis. Especially high-risk patients could profit from these measures.  
Additional randomized controlled trial RCTs need to be conducted to verify or refute a positive 
effect of sedation depth monitoring, various pharmaceutical prophylaxis (Haloperidol, Olanzapine 
and gabapentin), geriatric care units, fast-track surgery or the use of regional anesthesia techniques. 
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2. List of abbrevations 
BIS:   bispectral index 
CNS:   central nervous system 
EEG:   electroencephalogram 
FICB:  fascia iliaca compartment block 
FTS:  fast track surgery 
GABA:  gamma-aminobutyric acid 
ICU:   intensive care unit 
i.v.:  intravenous 
NIRS:  near-infrared spectroscopy 
POD:   post-operative delirium 
POCD:  post-operative cognitive dysfunction 
RCT:  randomized controlled trial 
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3. Introduction 
The increasing number of operations performed on elderly patients has raised the question whether 
anesthesia is harmful for the cerebral function in this patient category. Elderly patients frequently 
experience postoperatively an acute deterioration of their cerebral functions, resulting in postop-
erative delirium (POD) or postoperative cognitive dysfunction (POCD). The acute change in the 
neuropsychiatric state of the patient has a direct influence on the patients’ morbidity and mortality. 
So, to further understand the pathomechanism of anesthesia on the elderly brain, it is important to 
analyze its physiology and pathophysiology. 
3.1 Pathophysiology of age-related neuropsychiatric decline [1] 
3.1.1. Brain Volume 
Once a brain reaches the age of 45-50, a progressive decline in brain weight begins. As gray matter 
only increases in childhood and then starts decreasing slowly but continuously, white matter vol-
ume usually increases until the age of 45, explaining increases in connectivity between brain re-
gions, and thereafter starts to decrease. This explains the decrease in whole-brain-volume with 
ageing-associated losses, as age-related comorbidities like diabetes and hypertension can ad-
versely affect changes in white matter tracts [2]. 
3.1.2. Blood-Brain Barrier 
Age has a vast number of effects on the blood-brain barrier such as a decrease in microvascular 
density and capillary lumen size, as well as a reduction of the number of mitochondria per endo-
thelial cell. These affect the permeability of the blood-brain barrier [3]. Known risk factors for 
acceleration of these changes include diabetes mellitus, hyperlipidemia, hypertension and adverse 
drug reactions. The hypothesis that age-associated injury of the blood–brain barrier plays a role in 
the pathogenesis of white matter disease is vastly supported [3]. Age-related injury in the blood-
brain barrier might also modify the reaction to ischemia and the drug permeability into the CNS 
[3]. 
3.1.3. Neurogenesis 
Physiologically, neural stem cells are constitutively active in the hippocampal dentate gyrus and 
sub ventricular regions of the lateral ventricles, where they can develop into neurons at every given 
age [4]. This process called neurogenesis can cause neural plasticity that is involved in cognitive 
and emotional functions (dentate gyrus). However, neurogenesis decreases gradually with ageing, 
resulting in a worse ability to learn and contributing to cognitive decline [4]. 
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3.1.4. Inflammation 
The CNS can respond to stress by coordinating cytokine-mediated signals within the CNS with 
the peripheral immune system. The peripheral immune system can cause an inflammatory re-
sponse of the CNS, which can manifest as behavioral or cognitive changes. The CNS has its own 
immune cells, namely astrocytes, microglia and CNS-associated macrophages. Microglia are re-
sponsible for the response and propagation of signals emitted from the peripheral immune system. 
The best example is the perioperative period, during which microglia can release cytokines or 
perform macrophage-like responses. The production of cytokines can be prolonged or exagger-
ated, if an aged brain has an impaired anti-inflammatory feedback [5]. Increased inflammatory 
response combined with ageing and systemic diseases (e.g. hypertension) are associated with cog-
nitive changes [6]. 
3.1.5. Cognition 
There are two main ways how cognition changes with age. First, there is acquired knowledge (e.g. 
vocabulary) that improves up to ~60 years of age, after which it declines. Secondly, you can meas-
ure the processing speed (reasoning, memory and spatial cognitive abilities), which decline in a 
nearly linear fashion from early adulthood [7]. The most dramatic feature that declines with age is 
memory, as 40% of people aged over 60 suffer from a memory decline, which greatly affects the 
performance of daily living activities [8]. 
3.1.6. Cognitive Reserve 
Cognitive reserve (passive/active) is defined as the inconsistency between anatomic and functional 
age-related decline. The brain size or its neuronal count is referred to as passive cognitive reserve, 
and it is mostly measured by brain volume, synaptic count or dendritic branching. In comparison, 
active reserve, defined as functional cognitive integrity, is not easy to be measured. There is no 
'best measure’; nevertheless, it is usually better in people with higher socioeconomic status and 
educational attainment. It is known, that post-mortem Alzheimer's disease pathology and pre-mor-
tem cognitive function is modified in people with higher educational attainment; every year of 
education has a positive effect on the cognitive function for the same neuropathology [9]. A pa-
tient's cognitive reserve is a better indicator for their overall cognition, than their underlying neu-
ropathology [9]. Even though it is not known what exactly causes a decrease in functional cogni-
tive reserve, we can observe its manifestation: Decrease in activities of daily living, increased 
sensitivity to anesthetic agents and increased risk for POD & POCD. 
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3.1.7. Cerebrovascular Disease 
Age-related large vessel arteriosclerotic and small vessel angiopathic cerebrovascular diseases are 
associated with a few risk factors: Hypertension, diabetes mellitus, elevated plasma homocysteine 
and apolipoprotein E [10]. These changes in the cerebrovascular system can cause subclinical vas-
cular disease, a condition that is quantified on magnetic resonance images as white matter hyper 
intensities. Clinical manifestation associated with these lesions include changes in cognition, at-
tention, psychomotor speed and executive functions [11].   
3.2 Anesthesia and the elderly brain [1]  
Anesthetic agents exert their function on a small number of CNS targets, focusing on postsynaptic 
ligand-gated ion channels. Some of these agents affect excitatory receptors, whereas others act as 
potentiators of inhibitory synaptic receptors (e.g. gamma-aminobutyric acid receptors) [12]. Intra-
venous drugs are known to have an effect on a large variety of receptors: GABA (propofol, etomi-
date), alpha-2 (dexmetomidine), N-methyl-D-aspartate (ketamine), acetylcholine, adenosine and 
dopamine (opioids) [13]. However, inhalational anesthetics act on different ion channel receptors, 
including GABA, glycine, acetylcholine [14], glutamate, and serotonin [15]. The postoperative 
cognitive problems experienced by the elderly results from the variety and complexity of the in-
teractions between anesthetic drug and ion channels. The CNS cholinergic system is of special 
importance to neuropsychiatric postoperative decline, as there is a close relationship between cog-
nition and acetylcholine [16]. Therefore, the interaction between anesthetics and acetylcholine re-
ceptors may be of crucial importance. As prefrontal cholinergic neurons degenerate with rising 
age, elderly patients tend to be more susceptible to anesthesia-mediated depression of cholinergic 
neurotransmission than younger patients [17, 18]. It is therefore important to keep an eye on the 
anticholinergic medication in surgery patients. 
3.3 Monitoring the elderly brain during general anesthesia [1] 
Monitoring brain oxygenation/perfusion and depth of anesthesia may be a useful tool for reducing 
postoperative cognitive decline. An association between cerebral oxygen desaturation and worse 
cognitive outcomes [19] has been found by intraoperative near-infrared spectroscopy (NIRS). 
These studies are limited by non-uniform definitions of desaturation and cognitive decline, and 
inadequate sample-size. Therefore, results of those RCTs were inconclusive. In a similar study, 
the relevance of impaired age-related autoregulation of cerebral blood flow in elderly patients as 
a contributory factor to cerebral oxygen desaturation has been discussed but results remain incon-
clusive as well [20].  
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Available means of monitoring anesthetic depth are auditory evoked potentials and, more im-
portantly, the electroencephalogram (EEG, processed or raw). The bispectral index (BIS) monitor 
is the most commonly used EEG in clinical practice. Studies have concluded that improvement in 
postoperative cognitive outcomes would be possible by having 'lighter' levels of anesthesia [21, 
22]. Furthermore, there have been studies reporting no association or even the opposite effect be-
tween the monitored anesthesia depth and postoperative cognition [23, 24].  
3.4 The elderly patient and sedation [1] 
While general anesthesia mainly acts at the level of the brain, regional anesthesia either works in 
the peripheral nervous system, or near the spinal cord. Common clinical practice suggests sedation, 
when regional anesthesia is used. Even though this procedure is under-investigated, it is still 
widely employed in elderly patients, most often for orthopedic procedures. Clinical trials involving 
younger patients have established dosage and method of administration, even though they did not 
account for the different pharmacokinetics and pharmacodynamics in elderly patients. However, 
these results are invariably extrapolated and used on elderly patients, possibly resulting in periop-
erative cognitive alteration or over dosage [25]. Over dosage could be avoided by using patient-
controlled sedation, a method that has been applied in cataract surgery with a high level of patient 
satisfaction [26], even though it still needs validation for the elderly population and might be only 
of interest to patients with no pre-morbid cognitive dysfunction. 
Sedation monitoring may be a useful tool to prevent over dosage, clinical data suggests.  It appears 
to be more important to always monitor sedation depth, than to choose the right type of sedation 
monitor. The BIS monitoring, for example, does not correlate with clinical sedation scale scores 
[27].  
3.5 POD – classification & assessment [1] 
POCD definition: Acute-onset organic brain syndrome that usually develops within the first couple 
of postoperative days. Additionally, it must exhibit a fluctuating course and it is usually accompa-
nied by a disturbed circadian rhythm. 
3.5.1. Symptoms 
Inattention is the main symptom, even though other cognitive changes overlap, for example diso-
rientation or memory deficit. Delirium can be classified as hyperactive, hypoactive or mixed var-
iation depending on the change in psychomotor behavior [28]. Even though the hyperactive form 
looks more dramatic, the hypoactive form is usually more dangerous and is associated with rela-
tively higher mortality. It is often underdiagnosed as patients exhibit no symptoms on their own 
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and mostly just lay quietly and motionless. This presentation can be misunderstood as symptoms 
of dementia and/or depression [29]. POD symptoms usually arise 24-72 h after surgery (the first 
24 h are symptomless and therefore called lucid interval) and are distinguished from cognitive 
'emergence phenomena' which occur in the transition time from anesthesia to wakefulness [30]. If 
a patient shows one or more symptoms of delirium, but does not complete all the defined diagnos-
tic criteria, his diagnosis would not be POD but 'subsyndromal delirium' instead [31]. 
3.5.2. Epidemiology 
Depending on the type of surgery, the incidence of POD in elderly patients varies strongly, ranging 
from an average of 10% to 30-65% in hip fracture, cardiac and emergency surgery [32, 33]. There 
are specific irreversible risk factors such as advanced age, cognitive impairment, lower educational 
level and pre-existing medical conditions, as well as potentially reversible risk factors, e.g. mal-
nutrition, electrolyte imbalance, environmental disturbances, substance withdrawal (alcohol or 
medication), infection and pre-morbid CNS co-medication. In cognitively intact patients, severe 
pain and inadequate analgesia are individual risk factors for POD [34]. 
3.5.3. Pathogenesis 
While there is still no exact explanation to the pathogenesis of POD, it is generally assumed to be 
multifactorial. Studies suggest that changes in neurotransmitter levels of acetylcholine, dopamine 
and melatonin can lead to POD [35]. The high prevalence of POD after a long surgery has been 
explained by the inflammatory response to the stress of the surgery [36, 37]. An interesting dis-
covery has been the response of microglial cytokines to peripheral immune system stimuli in vitro: 
cultures exposed to isoflurane, sevoflurane and propofol each have a different cytokine responses 
[38]. High postoperative pain levels have also been identified as a cause for hyperactive delirium. 
[39] 
3.5.4. Prognosis 
As mentioned earlier, suffering from a POD has a negative impact on health prognosis. The longer 
and more severe POD is associated with higher postoperative mortality [40]. POD per se is asso-
ciated with short and long-term risk of death, prolonged hospital stay and higher rates of institu-
tionalization following discharge, ultimately increasing total health care expenses [40]. 
3.5.5. Assessment 
The most up to date definition of diagnostic criteria can be found in the International Sta- tistical 
Classification of Diseases and Related Health Problems, 10th Revision (ICD-10) and the Diagnos-
tic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) (Fig. 1). Apart from those 
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two, there are a number of other diagnostic tools that have been designed and validated to establish 
the diagnosis of POD. The most important one would be the confusion assessment method (CAM), 
which is specific, sensitive, reliable and comfortable to use [41]. Delirium is diagnosed as shown 
in Fig. 2: patients have to present inattention of acute onset with fluctuating course, combined with 
either disorganized thinking or altered consciousness. This method fails to separate delirium in 
terms of severity. To assess and diagnose POD in intubated and critically ill patients, a reliable 
CAM-ICU nonverbal screening tool has been developed [41].  Additionally, the Nursing Delirium 
screening scale, the Delirium Detection Score [42] and the Intensive Care Delirium Screening 
checklist (ICDSC) [43] are acceptable means to screen for delirium.     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2: POD assessment according to CAM. Fig. 1: Diagnostic criteria according to 
DSM-IV and ICD-10. 
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3.6 POD - Treatment and prevention [44] 
Emergency pharmacologic treatment is mostly not indicated. It would be needed in case of dan-
gerous agitation associated with hyperactive delirium [45]. At first, it is important to exclude or-
ganic issues and consider alternative treatment strategies. Haloperidol, a neuroleptic (antipsy-
chotic) agent should be considered for sedation, as it does not depress respiration [46]. However, 
haloperidol prophylaxis has different effects on delirium outcome, which will be discussed later. 
There is evidence that the use of delirium assessment scores in ICU setting can reduce haloperidol 
dosage and treatment duration [47]. Alternative measures would include treatment of sleep disor-
ders, immobility, dehydration, visual and hearing impairment and cognitive dysfunction. These 
measures reduce the incidence of delirium in hospitalized elderly patients [48]. In ICU patients, 
rehabilitation strategies consisting of interruption of sedation, physical and occupational therapy 
in the early days of illness, have been shown to reduce duration of delirium [49].  
Knowing that the biochemistry of the brain and the hormone regulation are strongly affected by 
medication, Clegg et al. reported a list of medicaments that should be avoided in patients at risk 
for POD: opioids, benzodiazepines, dihydropyridines and histamine H1-receptor agonist [50].  
There is no clinical guideline for prophylactic pharmacological therapy. However, it seems, that 
pain management is of utter importance. In mechanically ventilated ICU patients there is some 
evidence suggesting dexmedetomidine (2-adrenoreceptor) as a prophylactic medicament. Accord-
ing to Duggleby, this measure would increase the number of delirium-free days [51]. Dexme-
detomidine shows clear superiority over benzodiazepines, as it has an analgesic effect, does not 
cause respiratory depression and results in a different sedation, which enables the patient to be 
more interactive and communicative [52]. In comparison with lorazepam and midazolam, dexme-
detomidine resulted in shorter duration of mechanical ventilation and a reduced incidence of de-
lirium, with no effect on ICU or hospital stay [52 53]. 
The strongest factor associated with POD would be cognitive impairment, as delirium and demen-
tia are closely related [54]. Approximately 50% of patients suffering from delirium will develop 
dementia [55]. In addition, preoperative depression is a negative predictive factor, as it increases 
significantly the risk for POD [56]. 
Considering predisposing factors for POD is nearly impossible, nevertheless, a validated model 
has been developed for delirium prediction. It is based on four criteria evaluated using specific 
scales: Illness severity (Acute Physiology and Chronic Health Evaluation Score) [57], visual im-
pairment (Schnellen Test) [58], cognitive impairment (Mini Mental State Evaluation Score) [59] 
and serum urea/creatinine ratio [60]. Following this model, Kalisvaart reported an incidence of 
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POD of 37% in high-risk hip fracture surgery patients, compared to 3.8% in the low-risk group 
[61]. 
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4. Objectives 
 
Due to the confounding results in the literature with different approaches to prevent POD, using 
or not adequate POD diagnostic tools for clinical studies, we performed this qualitative systematic 
review. The aim of this review was to determine the efficacy of pharmacological and non-phar-
macological peri-operative interventions to decrease delirium 
Our research question was: “Which peri-operative interventions during non-cardiac surgery have 
been associated with a reduction in delirium within the first seven postoperative days?’ 
4.1. Why a qualitative systematic review? 
According to evidence based medicine (EBM), systematic reviews and meta-analyses of good 
quality studies can be the best form of evidence available for clinicians. EBM combines the best 
available research evidence along with clinical experience and patient needs and expectations [62]. 
This concept begun with Gordon Guyatt and his group at McMaster University in 1992 [63]. 
Since 1998 more than 1000 publications addressed the topic. Different factors contributed to the 
increased importance of EBM:  
• physicians daily need relevant information of best quality regarding diagnosis, treatment, 
and prognosis, 
• the traditional information sources are frequently old, not updated, or of excessive volume, 
• the divergence in improved clinical experience from decreased scientific study knowledge 
over time; and  
• time constraints with often only a few minutes per week for reading and review.  
Recent developments have helped to overcome these barriers such as:  
• new strategies for tracking and evaluating evidence, 
• journals focused on evidence-based medicine, 
• technological improvement for faster literature search; and 
• systematic reviews of healthcare studies [62]. 
In earlier times, expert opinion has been presented in narrative reviews which are not evidence-
based, and, consequently have limitations [64-65]. 
Unsystematic narrative reviews often include only research selected by the authors, increasing the 
risk of selection bias [66-67] Cook et al defined a systematic review as “the application of scientific 
 15 
strategies that limit bias by the systematic assembly, critical appraisal and synthesis of all relevant 
studies on a specific topic.” [68]. 
Therefore, systematic reviews are work intensive and require expertise in the subject, the literature 
and the review methods.  
Appropriate questions to be addressed in a systematic review are: 
• disease or condition frequency, 
• phenomena associated with disease or interventions, 
• diagnostic accuracy, 
• disease etiology and / or risk factors, 
• prognosis; and 
• intervention effects [69] 
Also, the aims of the systematic review have to be clarified. They can include: 
• summarizing an overwhelming amount of literature, 
• resolving literature conflicts, 
• clarifying the relative strengths and weaknesses of the literature on the specific question, 
• avoiding further redundant trials, 
• evaluating the need for a large clinical trial, 
• improving the statistical power of smaller studies, 
• enhancing the precision and / or identify a smaller treatment effect; and 
• improving the generalizability of treatment outcomes [70]. 
When studies have sufficiently similarities, a meta-analysis, with statistical pooling of data from 
individual studies, might be appropriate. When the results of several studies are apparently similar, 
a meta-analysis can lead to a more precise (narrower confidence intervals) overall estimate of the 
treatment effect. However, using very narrow inclusion criteria to create more homogenous data, 
lead to exclusion of patients with special characteristics, resulting in less generalizable data. There-
fore, it can be very inappropriate to pool dissimilar studies in a meta-analysis, but it is for sure 
never inappropriate to undertake a qualitative systematic review. If studies are dissimilar, a de-
scriptive summary of the studies in a qualitative systematic review should be performed. However, 
reviewers often narrow inclusion criteria to possibly avoid heterogeneity by including only studies 
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reporting a particular outcome, or by limiting the review to specific study designs [71] The draw-
back of this approach is it biases the review against potentially valuable studies not reporting an 
outcome in the requested manner [72]. Often, the studies meeting certain inclusion criteria may 
represent heterogeneous studies which should not be combined for statistical evaluation [73]. 
Therefore, a qualitative systematic review of available data following clearly defined methods 
allows clinicians a certain space in evaluating the best evidence.  
Systematic reviews and meta-analyses of Level 1 and 2 studies represent the highest level of evi-
dence.  
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5. Methods 
 
5.1. Qualitative systematic review configuration 
To avoid different bias the review configuration was performed according to the advises of differ-
ent experts [70, 74] and in accordance with the Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses (PRISMA) Statement [75] and the Cochrane Handbook for Systematic Re-
views of Interventions [76]. 
The following steps were performed to achieve a good qualitative systematic review: 
• Formulation of a clear research question 
• Literature Search 
• Data Extraction 
• Quality Appraisal 
• Data Analysis and Results 
• Interpretation of Results 
5.2. Literature search 
A computerized search of the electronic databases PubMed, EMBASE and the Cochrane Con-
trolled Trials Register for papers published between January 1990 and January 2016 was per-
formed. Only studies in the English language and performed on adults were considered. Maximally 
expanded search terms with Boolean operators for the terms (delirium).mp; (cognitive disor-
der).mp; and (surgery).mp. Exclusions were (cardiac surgery or coronary artery bypass or 
CABG).mp. Moreover, the clinical trials database, ClincalTrials.gov, was searched. An additional 
manual search for theme-related review articles and other relevant material was performed to iden-
tify other studies in a snowballing technique. A manual search of the reference lists of all included 
papers was also conducted for further eligible studies. All reviews, retrospective studies, letters, 
case reports, comment, editorials and guidelines were removed, as were duplicate publications. 
Duplicates were eliminated 
5.3. Eligibility criteria 
Eligible trials had to diagnose delirium using a test recommended by the Diagnostic and Statistical 
Manual of Mental Disorders (DSM): DSM-III; DSM-III-R; DSM IV [77] 
or by the International Classification of Diseases, 10th edition [78]. 
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We included only prospective studies like randomized controlled trials (RCTs) or cohort studies 
comparing two groups (intervention and no intervention) with assessment of delirium in the first 
7 postoperative days. Studies which used pre-operative and postoperative mini-mental state exam-
inations (MMSE) in the diagnosis of delirium were excluded. Case series without controls as well 
as retracted publications were excluded from the analysis. 
5.4. Data extraction 
Two reviewers independently assessed each title for inclusion (A.P., J.A.A.), and relevant abstracts 
were independently evaluated. If doubt existed regarding relevance, the full text article was as-
sessed. Both reviewers independently extracted in duplicate relevant information. Any conflicts 
were resolved by a third independent reviewer (A.B.). The relevant information extracted is pre-
sented in Table 1. 
This systematic review was performed in accordance with the PRISMA guidelines [79]. 
5.5. Risk of bias 
To avoid inclusion, bias all study designs allowing a good quality review (RCTs and cohort stud-
ies) were included without excluding any due to a quality score pre-screening. 
Two independent reviewers (C.O. and J.A.A.) performed the screening and assessed each title for 
inclusion, and relevant abstracts were independently evaluated. In the case of any doubt, the full 
text article was assessed. A third reviewer (A.B) was available to resolve possible conflicts. 
Two reviewers (A.P. and J.A.A.) independently extracted in duplicate relevant information. Pos-
sible conflicts were resolved by the third independent reviewer (A.B.). 
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6. Results 
6.1. Study selection 
 
We identified 1376 studies from our literature search, of which 39 studies were selected for full 
paper analysis. From these studies, 23 finally met the eligibility criteria and were included in the 
review. The seventeen excluded studies were extensively assessed but excluded because of a dif-
ferent primary outcome or insufficient assessment for POD. (Table 6)  
6.2. Study characteristics and risk of heterogeneity 
The detailed characteristics of the included studies are shown in tables 1&2. Even though most of 
the studies are randomized, prospective trials, a great heterogenicity among them was noted. Six 
different assessment methods where used. We found many valuable studies with insufficient as-
sessment tools such as the mini-mental state examinations, which we could not include in this 
review. Used in 12 studies, the CAM protocol was the most common method. Also, the time points 
for reading out where very heterogenous. Additionally, the studies vary in population size ranging 
from 11 to 1’028 patients. Moreover, the type of surgery varies widely with orthopedic procedures 
being the most frequently assessed ones (12 out of 23).  
6.3. Risk of bias across the studies 
To avoid inclusion, bias all study designs allowing a good quality review (RCTs, cohort studies, 
case control studies and case series with control groups) were included [74]. Compared to other 
reviews [80] we did not accept MMSE as diagnostic tool for postoperative delirium. Additionally, 
compared to another review [81] we did not include studies which were interrupted due to ran-
domization and other methodological problems. 
6.4. Results in individual studies  
Table 2 presents a summary of the setup protocols as well as the main results from each study, 
helping to compare the findings. Overall nine RCTs [82-84, 88-91, 100, 104] and one randomized, 
comparative clinical study [86] showed a significant impact on our primary outcome (delirium 
incidence) towards the study group. On the other hand, we have 10 RCTs [85, 87, 90, 93-96, 99, 
101, 103] and 3 randomized trials [97, 98, 102] that show no significant difference between the 
groups.  
In tables 3 – 5 the different interventions showing an impact and showing no impact on postoper-
ative delirium are summarized. Four different pharmaceutical interventions showed a positive ef-
fect: haloperidol [82, 100], diazepam/flunitrazepam [84], gabapentin [90], and olanzapine [94]. 
However, in two other studies [86, 103] haloperidol was shown not to be effective in preventing 
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postoperative delirium. Other medication like donepezil [87, 92, 98] and melatonin [102] showed 
no effect in preventing postoperative delirium. From the perioperative anesthetic interventions, the 
fascia iliaca compartment block for hip surgery [93] and a light sedation [95] compared to a deep 
sedation was shown to be effective. The use of propofol compared to sevoflurane [85], regional to 
general [88, 97] as well as the intraoperative use of N2O compared to O2 [89] had no impact on 
the incidence of POD. Additional positive perioperative measures were geriatric consultation with 
a specific set up for elderly patients showed to be effective [83, 99] as was the use of fast track 
surgery [104]. The use of light therapy [91, 96] and a different specific geriatric setup [101] did 
not show any effect on the incidence of postoperative delirium. 
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Study Design No. of 
patients 
Surgery Read Out Time Points of 
Read Out 
Kaneko et al. 
(1999) [82]. 
randomized, 
comparative 
clinical study 
78 GIT-surgery DSM-III-R On the 5th post-op 
day, information 
was gathered and 
evaluated 
Marcantonio et 
al. (2001) [83]. 
RCT 177 orthopaedic CAM Daily 
Aizawa et al. 
(2002) [84]. 
RCT 42 laparotomy DSM IV 2x/d for 7 days af-
ter surgery 
Nishikawa et al 
(2004) [85]. 
Randomized 
clinical trial 
50 laparoscopy DRS Three times daily 
until 3rd post-op 
day 
Kalisvaart et 
al. (2005) [86]. 
RCT 430 orthopaedic DSM IV, 
CAM, DRS 
Daily 
Liptzin et al. 
(2005) [87]. 
RCT 1038 orthopaedic DSM IV, 
CAM 
Daily 
Papaioannou 
et al. (2005) 
[88]. 
Randomized 
study 
47 elective surgery  DSM-III Daily until 3rd 
post-op day 
Leung et al. 
(2006) [89]. 
RCT 114 non-cardiac sur-
gery 
CAM 24 & 48h after sur-
gery. 
Leung et al. 
(2006) [90]. 
RCT 21 Spinal surgery CAM not really men-
tioned, I suppose 
according to the 
CAM protocol 
Taguchi et al. 
(2007) [91]. 
RCT 11 Oesophagal can-
cer surgery 
NEE-
CHAM 
Twice daily until 
5th post-op day. 
Samson et al. 
(2007) [92]. 
RCT 33 orthopaedic DSM-IV Three times daily 
until 4th post-op 
day 
Mouzopulus et 
al. (2009) [93]. 
RCT 219 orthopaedic DSM IV & 
CAM 
Daily 
Larsen et al. 
(2010) [94]. 
RCT 495 orthopaedic DSM-III-R, 
CAM 
Daily until 8th 
post-op day or dis-
charge 
Sieber et al. 
(2010) [95]. 
RCT 114 orthopaedic CAM From the second 
post-op day until 
discharge daily 
Ono et al. 
(2011) [96]. 
RCT 22 Oesophagectomy NEE-
CHAM & 
DSM-IV 
TR 
Twice daily until 
6th post-op day 
Slor et al. 
(2011) [97]. 
RCT 527 orthopaedic DSM-IV & 
CAM 
Daily until dis-
charge 
Marcantonio et 
al. (2011) [98]. 
RCT 16 orthopaedic CAM Daily until dis-
charge and after 2, 
4, 6 weeks for fol-
low-up 
Table 1. Study characteristics 
 22 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study Design No. of 
patients 
Surgery Read Out Time Points of 
Read Out 
Deschodt et al. 
(2012) [99]. 
RCT 171 orthopaedic CAM According to CAM 
(1,3,5,8,15 days 
post-op) 
Wang et al. 
(2012) [100]. 
RCT 457 non-cardiac sur-
gery 
CAM 1x/d until 7th post-
op day 
Hempenius et 
al. (2013) 
[101]. 
RCT 260 tumour-surgery DOS, 
DSM-IV, 
DRS-R-98 
Three times daily 
until discharge 
De Jonghe et 
al. (2014) 
[102]. 
RCT 378 orthopaedic DSM-IV Daily until 8th 
post-op day or dis-
charge 
Fukata et al. 
(2014) [103]. 
randomized, 
open-label pro-
spective trial 
119 GIT-surgery, or-
thopaedic 
NEE-
CHAM 
Daily until 7th 
post-op day 
Jia et al. 
(2014) [104]. 
RCT 233 GIT-surgery DRS-R-98 On admissdion, 
then daily until 5th 
post-op day 
Table 1 ff. Study characteristics 
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Study Special Setup Results 
Kaneko et al. 
(1999) [82]. 
78 patients who underwent gastrointestinal surgery 
received either 5 mg of haloperidol intravenously 
postoperatively at 21:00 for 5 consecutive days, or 
normal saline with the same schedule. 
There was a significant de-
crease in delirium incidence in 
the haloperidol group. 
Marcantonio 
et al. (2001) 
[83]. 
The subjects randomized to the intervention group 
underwent geriatric consultation preoperatively or 
within 24 hours postoperatively. A geriatrician per-
formed daily visits and made targeted recommenda-
tions based on a structured protocol. 
There was a statistically signif-
icant reduction of delirium in-
cidence in the geriatrician care 
group compared with the usual 
care group. 
Aizawa et al. 
(2002) [84]. 
Delirium-free protocol (DFP): Diazepam (0.1 
mg/kg) i.m. 20:00, Flunitrazepam (0.04 mg/ kg) i.v 
+ Pethidin (1 mg/KG) i.v 20:00 for 8 hours 
There was a significant de-
crease in delirium incidence in 
the DFP group. 
Nishikawa et 
al (2004) 
[85]. 
The patients were randomly assigned by a 
sealed envelope technique to a propofol group 
or a sevoflurane group. 
There was no significant dif-
ference between the incidences 
of delirium in the two groups 
during the first 3 days after 
surgery.  
Kalisvaart et 
al. (2005) 
[86]. 
Eligible patients were sequentially randomly as-
signed to study treatment (placebo or haloperidol 
0.5 mg three times daily) from a block of drugs that 
the hospital pharmacist had prepackaged.  
There was no significant dif-
ference between the incidences 
of delirium in the two groups. 
Liptzin et al. 
(2005) [87]. 
Patients were randomized separately by a research 
pharmacist to 5 mg of donepezil or placebo with 
breakfast. Subjects were given the study medication 
and told to begin taking it 14 days before the sur-
gery and to continue it for 14 days after the surgery. 
There was no significant dif-
ference between the incidences 
of delirium in the two groups. 
Papaioannou 
et al. (2005) 
[88]. 
Patients were randomly assigned by a computer pro-
gram to receive either general or regional anaesthe-
sia (epidural or spinal) with or without conscious 
sedation by propofol infusion to achieve a Ramsay 
sedation score of 2. 
There was no significant dif-
ference between the incidences 
of delirium in the two groups. 
Leung et al. 
(2006) [89]. 
The intraoperative anaesthetic management was 
randomized to either N2O with O2, or O2 (with or 
without air) plus a potent inhalational agent for both 
groups 
There was no significant dif-
ference between the incidences 
of delirium in the two groups. 
Leung et al. 
(2006) [90]. 
Either gabapentin 900 mg or placebo was ad-
ministered by mouth 1 to 2 hours before sur-
gery and anesthesia. This dose was continued 
for the first 3 postoperative days.  
The incidence of postopera-
tive delirium was higher in 
the placebo than in the 
gabapentin groups. 
 
 
 
Table 2. Study setups and main results 
 24 
 
 
 
Study Special Setup Results 
Taguchi et al. 
(2007) [91]. 
Bright light therapy was started on the day after ex-
tubation. The subjects were exposed to light for 2 h 
from 7:30 h to 9:30 h in the morning from days 2 to 
5 after surgery, in principle, with modifications ac-
cording to the condition of each patient. 
There was no significant dif-
ference between the incidences 
of delirium in the two groups. 
Samson et al. 
(2007) [92]. 
Subjects received their first dose of study medica-
tion post-operatively, therefore subjects took 5 mg 
of donepezil or placebo every 24 h from this time 
point (3 h) for three days. Thus the total duration of 
treatment was 4 days. 
There was no significant dif-
ference between the incidences 
of delirium in the two groups. 
Mouzopulus et 
al. (2009) 
[93]. 
FICB was administered with a 0.25 mg dose of 
0.3 mL/kg bupivacaine on admission and re-
peated daily every 24 h until delirium occur-
rence or hip surgery was performed. Twenty-
four hours after hip surgery the same dose of 
FICB was re-administered and repeated daily 
every 24 h until delirium occurrence or dis-
charge. 
The incidence of delirium in 
the FICB prophylaxis group 
was significantly lower 
from the incidence in the 
placebo group. 
Larsen et al. 
(2010) [94]. 
Olanzapine 5 mg or placebo were given immedi-
ately before and after surgery. 
The incidence of postoperative 
delirium was lower in the 
olanzapine group than in the 
placebo group for the entire 
sample. 
Sieber et al. 
(2010) [95]. 
Sedation depth was titrated using processed electro-
encephalography with the bispectral index (BIS), 
and patients were randomized to receive either deep 
(BIS, approximately 50) or light (BIS, ≥80) seda-
tion. 
The prevalence of postopera-
tive delirium was significantly 
lower in the light sedation 
group, indicating that 1 inci-
dent of delirium will be pre-
vented for every 4.7 patients 
treated with light sedation 
Ono et al. 
(2011) [96]. 
Beginning at Day 2, participants in the study group 
underwent two hours of bright light exposure start-
ing at 7:30 a.m. for a total of four days.  
There was no significant dif-
ference between the incidences 
of delirium in the two groups. 
Slor et al. 
(2011) [97]. 
Postoperative delirium was compared between 
groups receiving general and regional anesthesia 
and between groups with and without specific peri-
operatively administered drugs grouped according 
to class. 
There was no significant dif-
ference between the incidences 
of delirium in the two groups. 
 
 
 
 
 
 
Table 2 ff. Study setups and main results 
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Study Special Setup Results 
 
Marcan-
tonio et al. 
(2011) 
[98]. 
The research pharmacy placed donepezil 5 mg tablets into cap-
sules, and prepared matching capsules filled with placebo. The 
study drug was administered daily, unless adverse events su-
pervened, for a total treatment course of 30 days 
There was no signifi-
cant difference between 
the incidences of delir-
ium in the two groups. 
Deschodt 
et al. 
(2012) 
[99]. 
geriatric consultation: geriatrician nurse, social worker, occu-
pational therapist + physiotherapy, preoperative assessment 
Significantly more con-
trols than intervention 
group participants were 
delirious at any point 
after surgery.  
Wang et 
al. (2012) 
[100]. 
Study drug was administrated by bolus injection of 5 mL (0.5 
mg haloperidol or placebo), followed by continuous infusion at 
a rate of 1 mL/hr for 12 hours (0.1 mg/hr haloperidol or pla-
cebo). 
There was a significant 
decrease in delirium in-
cidence in the haloperi-
dol group.  
Hemp-
enius et al. 
(2013) 
[101]. 
Patients in the intervention group were assessed preoperatively 
by a geriatric team and monitored during their hospital stay. 
An individual treatment plan was drawn up paying specific at-
tention to patient-related risk factors for delirium, namely, cog-
nitive impairment, visual impairment, hearing impairment, 
malnutrition and impaired mobility. 
During their hospital stay, the patients in the intervention 
group were assessed daily by a geriatric nurse.  
There was no signifi-
cant difference between 
the incidences of delir-
ium in the two groups. 
De Jonghe 
et al. 
(2014) 
[102]. 
Patients received melatonin 3 mg or placebo in the evening for 
5 consecutive days, starting within 24 hours after admission. 
There was no signifi-
cant difference between 
the incidences of delir-
ium in the two groups. 
Fukata et 
al. (2014) 
[103]. 
Haloperidol 0.5A (2.5 mg) was dissolved in 100 ml of saline 
and intravenously administered by drip infusion once daily at 
18:00 from postoperative days 1 to 3 to the intervention group. 
The non-intervention group did not receive preventive treat-
ment. 
There was no signifi-
cant difference between 
the incidences of delir-
ium in the two groups. 
Jia et al. 
(2014) 
[104]. 
Patients were randomly assigned into the traditional therapy 
group (n =120) and the FTS group (n =120). 
The incidence of post-
operative delirium was 
significantly lower in 
patients with the fast 
track therapy than with 
the traditional therapy. 
 
 
 
Table 2 ff. Study setups and main results 
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Positive Effect on Primary Outcome No Effect on Primary Outcome 
Kaneko et al. (1999) [82]: 78 patients who under-
went gastrointestinal surgery received either 5 mg 
of haloperidol intravenously postoperatively at 
21:00 for 5 consecutive days, or normal saline 
with the same schedule. 
Kalisvaart et al. (2005) [86]: Eligible patients 
were sequentially randomly assigned to study 
treatment (placebo or haloperidol 0.5 mg 
three times daily) from a block of drugs that 
the hospital pharmacist had prepackaged. 
Aizawa et al. (2002) [84]: Delirium-free pro-
tocol (DFP): Diazepam (0.1 mg/ kg) i.m. 
20:00, Flunitrazepam (0.04 mg/ kg) i.v + 
Pethidin (1 mg/ kg) i.v 20:00 for 8 hours 
Liptzin et al. (2005) [87]: Patients were ran-
domized separately by a research pharmacist 
to 5 mg of donepezil or placebo with break-
fast. Subjects were given the study medica-
tion and told to begin taking it 14 days before 
the surgery and to continue it for 14 days after 
the surgery. 
Leung et al. (2006) [90]: Either gabapentin 
900 mg or placebo was administered by 
mouth 1 to 2 hours before surgery and anes-
thesia. This dose was continued for the first 3 
postoperative days. 
Samson et al. (2007) [92]. Subjects re-
ceived their first dose of study medication 
post-operatively, therefore subjects took 5 mg 
of donepezil or placebo every 24 h from this 
time point (3 h) for three days. Thus, the total 
duration of treatment was 4 days. 
Larsen et al. (2010) [94]: Olanzapine 5 mg or 
placebo were given immediately before and 
after surgery. 
Marcantonio et al. (2011) [98]: The research 
pharmacy placed donepezil 5 mg tablets into 
capsules, and prepared matching capsules 
filled with placebo. The study drug was ad-
ministered daily, unless adverse events super-
vened, for a total treatment course of 30 days 
Wang et al. (2012) [100]: Study drug was ad-
ministrated by bolus injection of 5 mL (0.5 
mg haloperidol or placebo), followed by con-
tinuous infusion at a rate of 1 mL/hr for 12 
hours (0.1 mg/hr haloperidol or placebo). 
De Jonghe et al. (2014) [102]. Patients re-
ceived melatonin 3 mg or placebo in the even-
ing for 5 consecutive days, starting within 24 
hours after admission. 
 Fukata et al. (2014) [103]: Haloperidol 0.5A 
(2.5 mg) was dissolved in 100 ml of saline and 
intravenously administered by drip infusion 
once daily at 18:00 from postoperative days 1 
to 3 to the intervention group. The non-inter-
vention group did not receive preventive 
treatment. 
Table 3: Perioperative pharmaceutical interventions 
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Positive Effect on Primary Outcome No Effect on Primary Outcome 
Mouzopulus et al. (2009) [93]: FICB was ad-
ministered with a 0.25 mg dose of 0.3 mL/kg 
bupivacaine on admission and repeated daily 
every 24 h until delirium occurrence or hip 
surgery was performed. Twenty-four hours 
after hip surgery the same dose of FICB was 
re-administered and repeated daily every 24 h 
until delirium occurrence or discharge. 
Nishikawa et al (2004) [86]: The patients 
were randomly assigned by a sealed envelope 
technique to a propofol group or a sevoflurane 
group. 
Sieber et al. (2010) [95]: Sedation depth was 
titrated using processed electroencephalog-
raphy with the bispectral index (BIS), and pa-
tients were randomized to receive either deep 
(BIS, approximately 50) or light (BIS, ≥80) 
sedation. 
Papaioannou et al. (2005) [88]. Patients were 
randomly assigned by a computer program to 
receive either general or regional anesthesia 
(epidural or spinal) with or without conscious 
sedation by propofol infusion to achieve a 
Ramsay sedation score of 2. 
 Leung et al. (2006) [89]: The intraoperative 
anesthetic management was randomized to ei-
ther N2O with O2, or O2 (with or without air) 
plus a potent inhalational agent for both 
groups 
 Slor et al. (2011) [97]: Postoperative delirium 
was compared between groups receiving gen-
eral and regional anesthesia and between 
groups with and without specific periopera-
tively administered drugs grouped according 
to class. 
Table 4: Perioperative anesthetic interventions 
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Positive Effect on Primary Outcome No Effect on Primary Outcome 
Marcantonio et al. (2001) [83]: The subjects 
randomized to the intervention group under-
went geriatric consultation preoperatively or 
within 24 hours postoperatively. A geriatri-
cian performed daily visits and made targeted 
recommendations based on a structured pro-
tocol. 
Taguchi et al. (2007) [91]: Bright light ther-
apy was started on the day after extubation. 
The subjects were exposed to light for 2 h 
from 7:30 h to 9:30 h in the morning from 
days 2 to 5 after surgery, in principle, with 
modifications according to the condition of 
each patient. 
Deschodt et al. (2012) [99]: geriatric consul-
tation: geriatrician nurse, social worker, occu-
pational therapist + physiotherapy, preopera-
tive assessment 
Ono et al. (2011) [96]: Beginning at Day 2, 
participants in the study group underwent two 
hours of bright light exposure starting at 7:30 
a.m. for a total of four days. 
Jia et al. (2014) [104]: Patients were randomly 
assigned into the traditional therapy group (n 
=120) and the FTS group (n =120). 
Hempenius et al. (2013) [101]: Patients in the 
intervention group were assessed preopera-
tively by a geriatric team and monitored dur-
ing their hospital stay. An individual treat-
ment plan was drawn up paying specific at-
tention to patient-related risk factors for delir-
ium, namely, cognitive impairment, visual 
impairment, hearing impairment, malnutri-
tion and impaired mobility. 
During their hospital stay, the patients in the 
intervention group were assessed daily by a 
geriatric nurse. 
Table 5: Other Perioperative Interventions 
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Study Reason for exclusion 
Beaussier et al. (2006) Primary Outcome is not delir, but the length of 
hospital stay. 
Akarsu et al. (2012) Assessment of POD was not sufficient 
(MMSE) 
Coi et al. (2012) Assessment of POD was not sufficient 
(MMSE) 
Jildenstal et al. (2011) Assessment of POD was not sufficient 
(MMSE) 
Chen et al. (2001) Assessment of POD was not sufficient 
(MMSE) 
Chan et al. (2013) Primary Outcome is not delir, but POCD inci-
dence after 3 Months 
Lundstrom et al. (2007) Primary Outcome is not delir, but number of 
days of postoperative delirium 
Berggren et al. (1987) Primary Outcome is not delir, but postopera-
tive confusion 
Kudoh et al. (2002) Primary outcome is not delir but deteriation of 
depressive symptoms. 
Gruber-Baldini et al. (2013) Primary outcome is severity of POD. 
Williams-Russo et al. (1995) Primary Outcome is change in cognitive func-
tion 
Nishikawa et al. (2007) Primary outcome is not delir, but the quality of 
postoperative analgesia. 
Kudoh et al. (2004) Primary outcome is not delir, but "Quality of 
anesthesia recovery such as nausea, vomiting, 
headache, pain 
Mann et al. (2000) Primary outcome is not delir, but pain relief. 
Lurati et al. (2012) Primary outcome is myokardial ischemia and 
not delir. 
Williams-Russo et al. (1999) Primary outcome is cognitive dysfunction and 
not delir. 
Musclow et al. (2012) Primary outcome is not delir, but the quality of 
postoperative analgesia. 
 
Table 6: Excluded studies  
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7. Discussion 
7.1. Main findings 
This review aims to analyze, summarize, and compare recent literature regarding perioperative 
measures to reduce incidence of POD in non-cardiac surgery. Twenty-three studies were analyzed 
(19 RCTs, 4 randomized clinical studies). (Tables 1&2) Given the great range of outcomes and 
measures analyzed, as well as the heterogenicity of the studies characteristics, the findings were 
inconclusive and interpretations prove to be difficult. Overall, the current findings are not suffi-
ciently robust to indicate clear guidelines for POD prophylaxis. 
7.2. Results in context 
According to our finding, perioperative geriatric consultations, which included multicomponent 
interventions, lighter as opposed to deeper anesthesia and the use of haloperidol seems to be ef-
fective in decreasing postoperative delirium. (Tables 3-5) 
Considering the depth of anesthesia, Sieber et al. found that light sedation (BIS > 80) during spinal 
anesthesia for orthopedic surgery decreased the occurrence of delirium by 50% when compared 
with deep sedation (BIS ~50) (p = 0.02) [95]. 
For perioperative geriatric consultation, the clinical trials are at a high risk of bias due to inade-
quate randomization and/or blinding. (Table 5) Also, the set up deep vs light anesthesia showed 
significant heterogeneity, and there may be publication bias associated with this intervention. 
These findings go in accordance with the review by Moyce Z. et al. [80]. Surprisingly, there seems 
to be no difference in the use of regional vs general anesthesia. (Table 4) This goes in accordance 
with a meta-analysis of the efficacy of general and regional anesthesia, which failed to show a 
significant difference (five studies) concerning postoperative delirium, but found that general an-
esthesia may increase the risk of developing postoperative cognitive dysfunction compared to re-
gional anesthesia [81]. 
We found a trend to protection with the use of haloperidol. (Table 3) However, the dose of 
haloperidol varied between the studies. Wang et al. [100] used 0.5 mg haloperidol as an intrave-
nous bolus postoperatively, followed by an infusion at 0.1 mg/h for 12 h; Kaneko et al. [82] ad-
ministered 5 mg haloperidol i.v. daily for five days, and Kalisvaart et al. [86] used oral haloperidol 
1.5 mg pre-operatively and continued for three days postoperatively.  
A recent meta-analysis by Teslyar P et al. [105] studied the antipsychotics as a group (haloperidol, 
olanzapine and risperidone) and also described a trend to a reduction in delirium with the peri-
operative use of antipsychotics. 
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Leung et al. [90] found that postoperative use of gabapentin decreased the incidence of delirium, 
which was probably due to a secondary opioid sparing effect. 
7.3. Strengths and limitations 
There are some limitations to this review. First, according to other meta-analysis dealing with 
delirium and postoperative cognitive dysfunction, most of the studies also included in this review 
seem to be under-powered [80]. Only further research with adequately powered studies will finally 
show if interventions like geriatric consultation or light sedation are efficient. Second, most of the 
studies were limited to orthopedic surgery. Delirium research needs to be extended to other non-
cardiac surgeries. Additionally, the nature of multi-component consultations includes the bias due 
to poor randomization and blinding. In the pharmacological intervention studies, there was no 
standardization of the anesthetic and pharmacological intervention techniques. We also excluded 
foreign language studies, which could have impacted the results of this review. Finally, only few 
studies assessed the pre-operative risks for delirium, and there was a lack of standardization con-
sidering the timing of postoperative testing.  
7.4. Implications for practice 
The main findings of this review are that peri-operative geriatric consultations involving multi-
component interventions, and lighter anesthesia, seem to be potentially effective in decreasing the 
outcome of delirium. The use of haloperidol is controversial but potentially beneficial. 
7.5. Implications for research 
The multifactorial nature of delirium possibly asks for a multiple intervention modality as shown 
in this review. The approach as peri-operative geriatric consultations have been shown to be pow-
erful interventions to decrease delirium. The peri-operative geriatric consultation is a proactive, 
comprehensive geriatric assessment along with management and rehabilitation to decrease the out-
come of delirium. This modality in combination with the use of antipsychotics and light sedation 
should be further studied in the elderly population. 
Moreover, despite regional anesthesia does not directly interfere with the brain function, good data 
are missing to correctly assess the possible advantages of these techniques. 
A standardized protocol for pre-operative risk assessment and outcome determination is also 
needed in future studies. 
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